General American Investors’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-281,409
| Closed | -$1K | – | 81 |
|
|
2019
Q3 | $1K | Hold |
281,409
| – | – | ﹤0.01% | 68 |
|
|
2019
Q2 | $3K | Hold |
281,409
| – | – | ﹤0.01% | 69 |
|
|
2019
Q1 | $5K | Hold |
281,409
| – | – | ﹤0.01% | 66 |
|
|
2018
Q4 | $1K | Hold |
281,409
| – | – | ﹤0.01% | 68 |
|
|
2018
Q3 | $73K | Hold |
281,409
| – | – | 0.01% | 68 |
|
|
2018
Q2 | $79K | Hold |
281,409
| – | – | 0.01% | 69 |
|
|
2018
Q1 | $75K | Hold |
281,409
| – | – | 0.01% | 68 |
|
|
2017
Q4 | $101K | Hold |
281,409
| – | – | 0.01% | 68 |
|
|
2017
Q3 | $197K | Hold |
281,409
| – | – | 0.02% | 61 |
|
|
2017
Q2 | $113K | Hold |
281,409
| – | – | 0.01% | 58 |
|
|
2017
Q1 | $114K | Hold |
281,409
| – | – | 0.01% | 61 |
|
|
2016
Q4 | $141K | Hold |
281,409
| – | – | 0.01% | 65 |
|
|
2016
Q3 | $317K | Hold |
281,409
| – | – | 0.03% | 61 |
|
|
2016
Q2 | $322K | Hold |
281,409
| – | – | 0.03% | 56 |
|
|
2016
Q1 | $511K | Hold |
281,409
| – | – | 0.05% | 53 |
|
|
2015
Q4 | $472K | Sell |
281,409
-578,591
| -67% | -$1.47M | 0.04% | 56 |
|
|
2015
Q3 | $2.58M | Hold |
860,000
| – | – | 0.23% | 56 |
|
|
2015
Q2 | $1.2M | Hold |
860,000
| – | – | 0.1% | 59 |
|
|
2015
Q1 | $903K | Buy |
860,000
+210,000
| +32% | +$286K | 0.07% | 59 |
|
|
2014
Q4 | $787K | Buy |
+650,000
| New | +$643K | 0.06% | 60 |
|
General American Investors's APDNW Position: Q4 2019 in Review
General American Investors sold out of Applied DNA Sciences Inc Warrant (APDNW) in Q4 2019, closing a stake of 281,409 shares — an estimated $1K sold.
General American Investors first reported a position in APDNW in Q4 2014 and held it in 20 quarters. The position peaked at $2.58M in Q3 2015. 0 funds tracked by Wall St. Rank hold APDNW as of Q4 2019.
- General American Investors reported no remaining Applied DNA Sciences Inc Warrant position as of Q4 2019 after selling out during the quarter.
- General American Investors sold 281,409 Applied DNA Sciences Inc Warrant shares in Q4 2019, an estimated $1K.
- General American Investors first reported a position in Applied DNA Sciences Inc Warrant in Q4 2014 and held it in 20 quarters.
- General American Investors's Applied DNA Sciences Inc Warrant position peaked at $2.58M in Q3 2015.
- 0 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q4 2019.
Based on General American Investors's 13F filing for Q4 2019, filed 20 Feb 2020.